Charles Hennekens
![Charles Hennekens](/assets/img/authors/unknown.jpg)
Charles Hennekens
overall reaction
My overall reaction is that I'm pleased, because we need the data.
acute almost attack benefit best cost death far heart lower rate ratio risk second therapy
Those having a heart attack will have a far lower risk of having a second heart attack, a stroke, or their death rate is lowered almost a quarter. Aspirin has the best benefit to risk ratio and benefit to cost ratio of any therapy of acute heart attacks.